Top News

October 12, 2022

Vita Therapeutics Closes $31 Million Series B Financing to Develop Cell Therapies for Neuromuscular Diseases and Cancers

Press Release

March 22, 2022

Vita Therapeutics Bolsters Leadership to Advance Multiple Technology Platforms

Press Release

July 23, 2021

Vita Therapeutics receives Orphan Drug Designation from FDA for new novel treatment

Press Release

801 W. Baltimore St.
STE 301
Baltimore, MD 21201

About UsOverviewLeadership TeamBoard of DirectorsScientific Co-FoundersScientific Advisory BoardOur TechnologyOverviewAutologous ApproachAllogeneic ApproachCareers
PipelineOverviewLGMD2AFSHDClinical TrialsNewsroomTop NewsPublicationsIn the NewsMedia InquiriesGet in Touch
Terms and Conditions
Privacy Policy
Cookies
Social Media
© 2022 Vita Therapeutics, Inc. All rights reserved